Novel gonadotropin‐releasing hormone antagonists with substitutions at position 5
- 21 December 2004
- journal article
- Published by Wiley in Peptide Science
- Vol. 80 (2-3) , 386-391
- https://doi.org/10.1002/bip.20195
Abstract
Gonadotropin‐releasing hormone (GnRH) antagonists with high potency and improved duration of action are needed for potential clinical applications. We synthesized four new antagonists (2–5) of GnRH homologues to Azaline B (1), with a common core sequence of [Aph(X)5, D‐Aph(Cbm)6]Azaline B. In these analogs, (X) contains hydrophobic aromatic moieties (like homoveratoyl in 2, homovanillyl in 3, 2,5‐dimethoxyphenylacetyl in 4, and 3,5‐dimethoxyphenylacetyl in 5) designed to improve the duration of action over that of Azaline B. These analogs were tested in vitro for their ability to antagonize the GnRH receptor and in vivo for duration of action in a castrated male rat assay. Analogs 2, 4, and 5 were potent in vitro, but were found to be short acting in vivo. However, analog 3 [Aph(Hvn)5,D‐Aph(Cbm)6]Azaline B is a potent human GnRH receptor antagonist in vitro (IC50 1.47 nM) and exhibits a longer duration of action than azaline B. © 2004 Wiley Periodicals, Inc. Biopolymers (Pept Sci), 2005Keywords
This publication has 20 references indexed in Scilit:
- THE GONADOTROPIN-RELEASING HORMONE ANTAGONIST ABARELIX DEPOT VERSUS LUTEINIZING HORMONE RELEASING HORMONE AGONISTS LEUPROLIDE OR GOSERELIN: INITIAL RESULTS OF ENDOCRINOLOGICAL AND BIOCHEMICAL EFFICACIES IN PATIENTS WITH PROSTATE CANCERJournal of Urology, 2001
- GnRH Antagonists: A New Generation of Long Acting Analogues Incorporatingp-Ureido-phenylalanines at Positions 5 and 6Journal of Medicinal Chemistry, 2000
- Gonadotropin-Releasing Hormone Antagonists: Novel Members of the Azaline B FamilyJournal of Medicinal Chemistry, 1995
- Gonadotropin-releasing hormone antagonists with N.omega.-triazolylornithine, -lysine, or -p-aminophenylalanine residues at positions 5 and 6Journal of Medicinal Chemistry, 1992
- Novel gonadotropin-releasing hormone antagonists: peptides incorporating modified N.omega.-cyanoguanidino moietiesJournal of Medicinal Chemistry, 1991
- GnRH Agonists and AntagonistsDrugs, 1988
- New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitroJournal of Medicinal Chemistry, 1986
- Luteinizing hormone-releasing hormone. Antiovulatory activity of analogs substituted in positions 2 and 6Journal of Medicinal Chemistry, 1975
- Synthetic luteinizing hormone releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminusJournal of Medicinal Chemistry, 1973
- Synthetic Polypeptide Antagonists of the Hypothalamic Luteinizing Hormone Releasing FactorScience, 1972